News
KSPHF
30.28
NaN%
--
Kissei Faces EU Setback as EMA Backs Revocation of TAVNEOS Authorization
TipRanks · 2d ago
Mizuho Securities Reaffirms Their Hold Rating on Kissei Pharmaceutical Co (KSPHF)
TipRanks · 06/24 10:06
Kissei Pharmaceutical Grants Restricted Stock to Board Members and Officers
TipRanks · 06/23 07:00
Kissei Pharmaceutical Co (KSPHF) was downgraded to a Hold Rating at Nomura
TipRanks · 06/05 13:22
Kissei Pharmaceutical Co (KSPHF) Receives a Hold from SBI Securities
TipRanks · 06/04 10:16
Kissei Pharmaceutical Sets Share Buyback Framework but Executes No Purchases in May
TipRanks · 06/03 06:55
Kissei Files Japan NDA for IDH1-Targeting AML Drug Olutasidenib
TipRanks · 05/27 07:01
Kissei Pharmaceutical Co (KSPHF) Receives a Buy from Jefferies
TipRanks · 05/25 10:28
Kissei Tightens Safety Warnings on TAVNEOS After Serious Liver Risk Cases
TipRanks · 05/21 05:22
Amgen’s Tavneos reportedly linked to 20 deaths in Japan
Seeking Alpha · 05/16 12:23
Kissei Restricts TAVNEOS Use in Japan After Global Safety and Data Concerns
TipRanks · 05/15 07:33
Kissei Pharmaceutical Posts Record Sales as R&D Investment and Overseas Growth Intensify
TipRanks · 05/12 08:50
Kissei Pharmaceutical Launches ¥6 Billion Share Buyback and Cancellation Plan
TipRanks · 05/11 08:05
Kissei Pharmaceutical Details FY2026 Results and R&D Pipeline in Supplementary Report
TipRanks · 05/11 08:04
Kissei Pharmaceutical Swings to Operating Loss but Lifts Payouts and Eyes Profit Recovery
TipRanks · 05/11 08:04
Analysts Offer Insights on Healthcare Companies: Kissei Pharmaceutical Co (OtherKSPHF), Recursion Pharmaceuticals (RXRX) and ACADIA Pharmaceuticals (ACAD)
TipRanks · 05/07 10:20
Jefferies Sticks to Their Buy Rating for Kissei Pharmaceutical Co (KSPHF)
TipRanks · 05/03 12:26
Kissei sublicenses AML drug olutasidenib to Orient EuroPharma in Taiwan
TipRanks · 05/01 07:04
Kissei Pharmaceutical Names Research Chief Keiji Miyazawa as New President and COO
TipRanks · 04/24 08:23
Kissei Pharmaceutical Co (KSPHF) Receives a Buy from Nomura
TipRanks · 04/06 10:08
More
Webull provides a variety of real-time KSPHF stock news. You can receive the latest news about Kissei Pharm through multiple platforms. This information may help you make smarter investment decisions.
About KSPHF
Kissei Pharmaceutical Co Ltd is a Japan-based company mainly engaged in the pharmaceutical business. The Company operates through four segments. The Pharmaceutical segment manufactures and sells prescription drugs, and also purchases and sells healthcare foods such as prescription drugs and foods for special medical purposes. The Goods Sales segment is engaged in the development, production and sale of noodles, the sale of various equipment, vehicles and fuel, as well as insurance agency business. The Information Services segment operates in three areas including system integration services, system resource services such as information-related equipment rental and network construction, and medical system development and sales. The Construction and Facility Maintenance segment provides comprehensive construction services ranging from building construction to the maintenance and management of equipment and facilities.